The Global Point-of-Care (POC) Diagnostics Market is projected to expand at a CAGR of 11% through 2028. Growth is being fueled by the rising burden of infectious diseases, increasing demand for rapid ...

Point-of-care testing refers to diagnostic procedures conducted near the patient or at the site of care, outside of ...

Global Heparin Market OverviewThe Global Heparin Market is projected to grow steadily at a CAGR of approximately 5% by 2026.

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast period. This rapid expansion is primarily fueled by the rising prevalence of ...

The global weight management market is projected to grow at a rate of 9-10% by 2029. This expansion is driven by several key ...

Introduction to AuditsIn the fields of pharmaceuticals and medical devices where regulation is imposed, compliance with the quality standards set by the authorities is vital for the protection of the ...

Decentralized Clinical Trials Market OverviewThe global decentralized clinical trials (DCTs) market is witnessing strong momentum and is valued at approximately USD 8.8 billion in 2025, with ...

Global Liquid Biopsy Market OverviewThe global liquid biopsy market is anticipated to register a strong compound annual growth rate of around 17% through 2031, driven by the increasing global burden ...

The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...

The global home healthcare services market is projected to grow at a compound annual growth rate (CAGR) of approximately 9–10% through 2029. Market expansion is primarily driven by a rapidly aging ...

Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP).The CEP serves to attest that the quality of an active ...

Streamlining of selected non‑strategic early-stage programs completed, consistent with previously announced three-year 2026-2028 strategic plan·         No impact on cash runway or financing ...